These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38386240)

  • 21. Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital.
    Yeung WW; Ma BB; Lee JF; Ng SS; Cheung MH; Ho WM; Tsang MW; Chu S; Lam DC; Mo FK
    Hong Kong Med J; 2016 Dec; 22(6):546-55. PubMed ID: 27795447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
    Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
    Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
    Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
    Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in Radiotherapy for Rectal Cancer.
    Lin T; Narang A
    Surg Oncol Clin N Am; 2023 Jul; 32(3):461-473. PubMed ID: 37182987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological Outcomes in Patients With Locally Advanced Rectal Cancer Undergoing Preoperative Short-
    Kim JS; Chung MJ; Lee DY; Lee SH; Jeong SK; Yoo BE; Chung CS; Chung WK
    In Vivo; 2023; 37(6):2768-2775. PubMed ID: 37905618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 27. Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
    Noticewala SS; Das P
    Cancer J; 2024 Jul-Aug 01; 30(4):227-231. PubMed ID: 39042772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?
    Glynne-Jones R; Grainger J; Harrison M; Ostler P; Makris A
    Br J Cancer; 2006 Feb; 94(3):363-71. PubMed ID: 16465172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective use of radiation for locally advanced rectal cancer: one size does not fit all.
    Roxburgh CS; Weiser MR
    Minerva Chir; 2018 Dec; 73(6):592-600. PubMed ID: 29806758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma.
    Jia AY; Narang A; Safar B; Zaheer A; Murphy A; Azad NS; Gearhart S; Fang S; Efron J; Warczynski T; Hacker-Prietz A; Meyer J
    Radiat Oncol; 2019 Aug; 14(1):147. PubMed ID: 31426827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.
    Sclafani F; Brown G; Cunningham D; Rao S; Tekkis P; Tait D; Morano F; Baratelli C; Kalaitzaki E; Rasheed S; Watkins D; Starling N; Wotherspoon A; Chau I
    Oncologist; 2017 Jun; 22(6):728-736. PubMed ID: 28476941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term outcomes of neoadjuvant chemotherapy with capecitabine plus oxaliplatin for patients with locally advanced rectal cancer followed by total or tumor-specific mesorectal excision with or without lateral pelvic lymph node dissection.
    Sakamoto W; Kanke Y; Onozawa H; Okayama H; Endo H; Fujita S; Saito M; Saze Z; Momma T; Kono K
    Fukushima J Med Sci; 2022 Aug; 68(2):89-95. PubMed ID: 35732415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Chemotherapy in the Neoadjuvant/Adjuvant Setting for Patients With Rectal Adenocarcinoma Undergoing Chemoradiotherapy and Surgery or Radiotherapy and Surgery.
    Ahmed S; Eng C
    Curr Oncol Rep; 2018 Jan; 20(1):3. PubMed ID: 29362905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selecting patients with locally advanced rectal cancer for neoadjuvant treatment strategies.
    Dewdney A; Cunningham D; Chau I
    Oncologist; 2013; 18(7):833-42. PubMed ID: 23821325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer: A Comparison of Short- and Long-term Oncologic Outcomes.
    Goffredo P; Khan A; Mott SL; Jensen CC; Madoff RD; Gaertner WB; You YN; Hassan I
    Ann Surg; 2022 Dec; 276(6):e819-e824. PubMed ID: 34353995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial.
    Kim MJ; Lee DW; Kang HC; Park JW; Ryoo SB; Han SW; Kim KS; Chie EK; Oh JH; Jeong WK; Kim BH; Nam EM; Jeong SY
    BMC Cancer; 2023 Aug; 23(1):734. PubMed ID: 37553666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT).
    van den Berg K; Schaap DP; Voogt ELK; Buffart TE; Verheul HMW; de Groot JWB; Verhoef C; Melenhorst J; Roodhart JML; de Wilt JHW; van Westreenen HL; Aalbers AGJ; van 't Veer M; Marijnen CAM; Vincent J; Simkens LHJ; Peters NAJB; Berbée M; Werter IM; Snaebjornsson P; Peulen HMU; van Lijnschoten IG; Roef MJ; Nieuwenhuijzen GAP; Bloemen JG; Willems JMWE; Creemers GJM; Nederend J; Rutten HJT; Burger JWA
    BMC Cancer; 2022 Sep; 22(1):957. PubMed ID: 36068495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant radiotherapy for rectal cancer management.
    Feeney G; Sehgal R; Sheehan M; Hogan A; Regan M; Joyce M; Kerin M
    World J Gastroenterol; 2019 Sep; 25(33):4850-4869. PubMed ID: 31543678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
    Guckenberger M; Saur G; Wehner D; Thalheimer A; Kim M; Germer CT; Flentje M
    Radiother Oncol; 2013 Aug; 108(2):326-30. PubMed ID: 24021342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.